Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Bicheng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8837-8512; OpenAlex author ID A5101450020. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers

Papers 8

  1. Agrimoniin sensitizes pancreatic cancer to apoptosis through ROS-mediated energy metabolism dysfunction. Co-author DOI 10.1016/j.phymed.2021.153807↗
  2. Periplocin Induces Apoptosis of Pancreatic Cancer Cells through Autophagy via the AMPK/mTOR Pathway. Co-author DOI 10.1155/2022/8055004↗
  3. Paracrine production of IL-6 promotes a hypercoagulable state in pancreatic cancer. Co-author PMID 35018238↗
  4. Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer. Last author DOI 10.7150/jca.38616↗
  5. The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-019-0828-8↗
  6. High Glucose-Induced ROS Production Stimulates Proliferation of Pancreatic Cancer via Inactivating the JNK Pathway. Co-author DOI 10.1155/2018/6917206↗
  7. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles. Last author DOI 10.7754/clin.lab.2018.171124↗
  8. Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase… Co-author DOI 10.2147/ott.s91511↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lihong Yang · 2 shared papers, 2021–2022 · strength 0.32
  2. Hewei Zhang · 2 shared papers, 2022 · strength 0.31
  3. Yangyang Guo · 2 shared papers, 2019–2020 · strength 0.24
  4. Xiandong Zhu · 2 shared papers, 2018–2022 · strength 0.23
  5. Mengtao Zhou · 3 shared papers, 2015–2019 · strength 0.23
  6. Keqing Shi · 2 shared papers, 2018–2019 · strength 0.21
  7. Yukai Xiang · 2 shared papers, 2018–2019 · strength 0.17
  8. Silu Wang · 1 shared paper, 2021 · strength 0.16
  9. Gangyin Xie · 1 shared paper, 2022 · strength 0.16
  10. Jiawei Chen · 1 shared paper, 2022 · strength 0.16
  11. Linxiao Sun · 1 shared paper, 2022 · strength 0.15
  12. Guihua Jin · 1 shared paper, 2020 · strength 0.15
  13. Yongheng Bai · 1 shared paper, 2020 · strength 0.15
  14. Zongjing Chen · 1 shared paper, 2018 · strength 0.12
  15. Jie Zhang · 1 shared paper, 2019 · strength 0.09
  16. Wanqing Weng · 1 shared paper, 2019 · strength 0.09
  17. Weiguo Huang · 1 shared paper, 2019 · strength 0.09
  18. Jiao Min Luo · 1 shared paper, 2018 · strength 0.08
  19. Fubiao Ni · 1 shared paper, 2018 · strength 0.08
  20. Li Ding · 1 shared paper, 2018 · strength 0.08
  21. Xince Huang · 1 shared paper, 2015 · strength 0.06
  22. Yuwu Xiao · 1 shared paper, 2015 · strength 0.06
  23. Shengjie Dai · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.